5th GBHI Conference [Conferences / Workshops]

posted by Helmut Homepage – Vienna, Austria, 2021-02-02 16:26 (512 d 18:42 ago) – Posting: # 22202
Views: 2,061

(edited by Helmut on 2021-12-03 16:00)

Dear all,

the 5th conference of

The Global Harmonisation Initiative

is planned for April 6–7, 2022 in Amsterdam, The Netherlands.

Sessions:
  1. Fed vs fasted studies for immediate release dosage forms: Relevance of excipients, disintegration/dissolution speci­fi­ci­ties, drug substance properties and physiological GI conditions – new findings shall help achieve harmonisation
  2. Statistical considerations for BE assessment: Replicate design for BE of Highly Variable Drugs, two-stage design and PK modelling as supportive tools for BE assessment
  3. Topical products: Scientifically-based approaches for a waiver of clinical endpoint trials
  4. Narrow therapeutic index drugs: Study design and acceptance criteria

Update: Postponed; new dates September 28 – 29, 2022. Website, Programme.
The early-bird registration ends on June 15, 2022.

Dif-tor heh smusma 🖖 [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
22,181 posts in 4,647 threads, 1,572 registered users;
online 11 (1 registered, 10 guests [including 6 identified bots]).
Forum time: Thursday 12:09 CEST (Europe/Vienna)

The only way to comprehend what mathematicians mean by Infinity
is to contemplate the extent of human stupidity.    Voltaire

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5